OrthoPediatrics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
For the full year, sales was USD 148.73 million compared to USD 122.29 million a year ago. Net loss was USD 20.97 million compared to net income of USD 1.26 million a year ago. Basic loss per share from continuing operations was USD 0.92 compared to basic earnings per share from continuing operations of USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.92 compared to diluted earnings per share from continuing operations of USD 0.06 a year ago.